ANTIBODY ENGINEERING Joud Shafiq. ANTIBODY ENGINEERING ANTIBODIES METHODOLOGIES APPLICATIONS.

30
ANTIBODY ENGINEERING Joud Shafiq

Transcript of ANTIBODY ENGINEERING Joud Shafiq. ANTIBODY ENGINEERING ANTIBODIES METHODOLOGIES APPLICATIONS.

Page 1: ANTIBODY ENGINEERING Joud Shafiq. ANTIBODY ENGINEERING ANTIBODIES METHODOLOGIES APPLICATIONS.

ANTIBODY ENGINEERING

Joud Shafiq

Page 2: ANTIBODY ENGINEERING Joud Shafiq. ANTIBODY ENGINEERING ANTIBODIES METHODOLOGIES APPLICATIONS.

ANTIBODY ENGINEERING

• ANTIBODIES

• METHODOLOGIES

• APPLICATIONS

Page 3: ANTIBODY ENGINEERING Joud Shafiq. ANTIBODY ENGINEERING ANTIBODIES METHODOLOGIES APPLICATIONS.

Heavy chain

Light chain

220 a.a

~500 a.a

NH2

IMMUNOGLOBULIN

Page 4: ANTIBODY ENGINEERING Joud Shafiq. ANTIBODY ENGINEERING ANTIBODIES METHODOLOGIES APPLICATIONS.

Antigen Binding Site

Variable

Regions

Constant Regions

Effector

Functions

Page 5: ANTIBODY ENGINEERING Joud Shafiq. ANTIBODY ENGINEERING ANTIBODIES METHODOLOGIES APPLICATIONS.

LIGHT CHAIN GENES

Variable domain

CDR3

Page 6: ANTIBODY ENGINEERING Joud Shafiq. ANTIBODY ENGINEERING ANTIBODIES METHODOLOGIES APPLICATIONS.

HEAVY CHAIN GENES

HUMAN

H.C Variable region= V+D+J gene segments

Page 7: ANTIBODY ENGINEERING Joud Shafiq. ANTIBODY ENGINEERING ANTIBODIES METHODOLOGIES APPLICATIONS.

ANTIBODY ENGINEERING

Page 8: ANTIBODY ENGINEERING Joud Shafiq. ANTIBODY ENGINEERING ANTIBODIES METHODOLOGIES APPLICATIONS.

MONOCLONAL ANTIBODIES

Mouse splenocytes

Mouse myeloma

hybridoma

Y Y YMonoclonal

Y Y

Antibodies

Y Y

Page 9: ANTIBODY ENGINEERING Joud Shafiq. ANTIBODY ENGINEERING ANTIBODIES METHODOLOGIES APPLICATIONS.

PROBLEMS

• HAMA Response.

• Loss of effector functions.

• Reduce the size of antibody.

Page 10: ANTIBODY ENGINEERING Joud Shafiq. ANTIBODY ENGINEERING ANTIBODIES METHODOLOGIES APPLICATIONS.

• Production of human Mab.

• Make mouse Ab more “human-like”

• Production of small Ab fragments.

SOLUTIONS

Page 11: ANTIBODY ENGINEERING Joud Shafiq. ANTIBODY ENGINEERING ANTIBODIES METHODOLOGIES APPLICATIONS.

c cCH1CH1

CH2 CH2

CH3CH3

HINGE

Page 12: ANTIBODY ENGINEERING Joud Shafiq. ANTIBODY ENGINEERING ANTIBODIES METHODOLOGIES APPLICATIONS.

PROTEASE DIGESTION

c cCH1CH1

c cCH1CH1

HINGE

F(ab`)2

FabFab

Page 13: ANTIBODY ENGINEERING Joud Shafiq. ANTIBODY ENGINEERING ANTIBODIES METHODOLOGIES APPLICATIONS.

.HAMA Response.

•Loss of effector functions.

Making the antibody more “human-like”. (the cutting and pasting)

Production of human Mab’s.

Chimeric Ab’s Humanized Ab’s

Hybridoma

Phage Display

Transgenic/SCID Mice

Page 14: ANTIBODY ENGINEERING Joud Shafiq. ANTIBODY ENGINEERING ANTIBODIES METHODOLOGIES APPLICATIONS.

CHIMERIC HUMAN/MOUSE

FR1 FR2 FR3 FR4

CDR1 CDR2 CDR3

CONSTANT

CONSTANT

CONSTANTFR1 FR2 FR3 FR4

CDR1 CDR2 CDR3

Mouse

Human

Chimeric

Page 15: ANTIBODY ENGINEERING Joud Shafiq. ANTIBODY ENGINEERING ANTIBODIES METHODOLOGIES APPLICATIONS.

Human Mouse

Chimeric

Page 16: ANTIBODY ENGINEERING Joud Shafiq. ANTIBODY ENGINEERING ANTIBODIES METHODOLOGIES APPLICATIONS.

HUMANIZED ANTIBODIES

FR1 FR2 FR3 FR4

CDR1 CDR2 CDR3

CONSTANT

CONSTANT

CONSTANTFR1 FR2 FR3 FR4

CDR1 CDR2 CDR3

Mouse

Human

Humanized

Page 17: ANTIBODY ENGINEERING Joud Shafiq. ANTIBODY ENGINEERING ANTIBODIES METHODOLOGIES APPLICATIONS.

Human Mouse

Humanized

Page 18: ANTIBODY ENGINEERING Joud Shafiq. ANTIBODY ENGINEERING ANTIBODIES METHODOLOGIES APPLICATIONS.

CHIMERIC/HUMANIZED.Reduce the HAMA response.

.Maintain effector functions.

.Increase the half life of the antibody.

.Maintain binding affinity.

.Easy to construct.

Page 19: ANTIBODY ENGINEERING Joud Shafiq. ANTIBODY ENGINEERING ANTIBODIES METHODOLOGIES APPLICATIONS.
Page 20: ANTIBODY ENGINEERING Joud Shafiq. ANTIBODY ENGINEERING ANTIBODIES METHODOLOGIES APPLICATIONS.

ANTIBODY ENGINEERING

Page 21: ANTIBODY ENGINEERING Joud Shafiq. ANTIBODY ENGINEERING ANTIBODIES METHODOLOGIES APPLICATIONS.

.HAMA Response.

•Loss of effector functions.

Making the antibody more “human-like”. (the cutting and pasting)

Production of human Mab’s.

Chimeric Ab’s Humanized Ab’s

Hybridoma

Phage Display

Transgenic/SCID Mice

Page 22: ANTIBODY ENGINEERING Joud Shafiq. ANTIBODY ENGINEERING ANTIBODIES METHODOLOGIES APPLICATIONS.

MONOCLONAL ANTIBODIES

Mouse splenocytes

Mouse myeloma

hybridoma

Y Y YMonoclonal

Y Y

Antibodies

Y Y

Page 23: ANTIBODY ENGINEERING Joud Shafiq. ANTIBODY ENGINEERING ANTIBODIES METHODOLOGIES APPLICATIONS.

HUMAN HYBRIDOMAS

. Unstable hybridomas.

.Small number of human B-cells in peripheral blood.

. Obtaining antigen-reactive human B-cells.

Heteromyeloma

fusion

In vitro immunization

Page 24: ANTIBODY ENGINEERING Joud Shafiq. ANTIBODY ENGINEERING ANTIBODIES METHODOLOGIES APPLICATIONS.

MICE

SCIDTransgenic

Reconstituted with human peripheral blood

Containing human immunoglobulin genes.

Page 25: ANTIBODY ENGINEERING Joud Shafiq. ANTIBODY ENGINEERING ANTIBODIES METHODOLOGIES APPLICATIONS.

PHAGE DISPLAY

Page 26: ANTIBODY ENGINEERING Joud Shafiq. ANTIBODY ENGINEERING ANTIBODIES METHODOLOGIES APPLICATIONS.

Reduce the size of Antibody. Production of

antibody fragments.

Simplifying the expression/production of antibodies.

Page 27: ANTIBODY ENGINEERING Joud Shafiq. ANTIBODY ENGINEERING ANTIBODIES METHODOLOGIES APPLICATIONS.

ANTIBODY FRAGMENTS

Page 28: ANTIBODY ENGINEERING Joud Shafiq. ANTIBODY ENGINEERING ANTIBODIES METHODOLOGIES APPLICATIONS.

EXPRESSION SYSTEMS

Fungal Mammalian cell lines

Bacterial

Page 29: ANTIBODY ENGINEERING Joud Shafiq. ANTIBODY ENGINEERING ANTIBODIES METHODOLOGIES APPLICATIONS.
Page 30: ANTIBODY ENGINEERING Joud Shafiq. ANTIBODY ENGINEERING ANTIBODIES METHODOLOGIES APPLICATIONS.